Aterian Q2 Revenue Falls 30 Percent

Aterian (ATER) reported a sharp Q2 2025 revenue decline of 30.5% to $19.5 million and a $2.2 million adjusted EBITDA loss, primarily attributed to tariff-induced price increases on Amazon that, due to Amazon 1P's price stability and the platform's algorithm, significantly eroded sales velocity. In response, management has executed $5.5 million in annualized cost reductions, initiated supply chain diversification away from China, and is accelerating a strategic pivot towards higher-margin, U.S.-sourced consumables to reduce tariff exposure and enhance profitability. The company reaffirmed improved second-half 2025 guidance for $36-$38 million in net revenue and near breakeven adjusted EBITDA, indicating a focus on operational stabilization and cash preservation without immediate plans for equity raises.

Analysis

Aterian reported a severe contraction in Q2 2025, with net revenue declining 30.5% year-over-year to $19.5 million and adjusted EBITDA swinging to a $2.2 million loss from a $200,000 gain in the prior year. The primary driver of this underperformance was a sharp drop in sales velocity on its main channel, Amazon, after the company proactively raised prices to offset tariff-related cost pressures. This action was not matched by Amazon's first-party (1P) offerings, Aterian's key competitor in certain categories, making Aterian's products uncompetitive and triggering an adverse algorithmic response. In response, management is executing a multi-faceted turnaround strategy, having already secured $5.5 million in annualized fixed cost savings primarily from headcount reductions. Concurrently, the company is de-risking its supply chain by shifting production from China to Indonesia, reducing Chinese-sourced goods from 100% to 65%. The most significant strategic shift is an acceleration toward higher-margin, U.S.-sourced consumables, such as the upcoming Squatty Potty flushable wipes, to mitigate tariff exposure and improve structural profitability. Despite the weak Q2, management reaffirmed H2 2025 guidance for $36-$38 million in revenue and a near-breakeven adjusted EBITDA, signaling a significant operational improvement from the first half and stating that no equity raise is anticipated this year.

Key Decisions for Investors

• Investors should view Aterian as a high-risk turnaround play, where the investment thesis hinges on management's ability to successfully execute its pivot to consumables and meet its reaffirmed second-half guidance for near-breakeven adjusted EBITDA.
• Monitor the competitive dynamics on Amazon closely, as the Q2 results demonstrate a significant vulnerability to Amazon 1P's pricing strategy and the platform's sales algorithm, which remains a material risk to the core hardware business.
• Track the market success and margin contribution of new U.S.-sourced consumable launches, such as the Squatty Potty wipes and upcoming Healing Solutions products in October, as these are critical to validating the long-term strategy for margin expansion and revenue diversification.
• Consider the company's improved liquidity position and cost structure, but remain cautious until the cost-saving benefits are fully realized in 2026 and revenue growth stabilizes.